L3Harris Technologies Stock in Brief

By Ken Smith • Tuesday, December 05 19:24 • Permanent Link

L3Harris Technologies logged a -0.6% change during today's evening session, and is now trading at a price of $198.01 per share. The S&P 500 index moved -0.0%. LHX's trading volume is 1,354,606 compared to the stock's average volume of 1,305,058.

L3Harris Technologies trades -10.56% away from its average analyst target price of $221.38 per share. The 21 analysts following the stock have set target prices ranging from $162.0 to $338.0, and on average have given L3Harris Technologies a rating of buy.

If you are considering an investment in LHX, you'll want to know the following:

L3Harris Technologies's current price is 48.6% above its Graham number of $133.24, which implies that at its current valuation it does not offer a margin of safety
L3Harris Technologies has moved -9.0% over the last year, and the S&P 500 logged a change of 17.0%
Based on its trailing earnings per share of 7.77, L3Harris Technologies has a trailing 12 month Price to Earnings (P/E) ratio of 25.5 while the S&P 500 average is 15.97
LHX has a forward P/E ratio of 14.9 based on its forward 12 month price to earnings (EPS) of $13.28 per share
The company has a price to earnings growth (PEG) ratio of 14.18 — a number near or below 1 signifying that L3Harris Technologies is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 2.01 compared to its sector average of 4.06
L3Harris Technologies, Inc., an aerospace and defense technology company, provides mission-critical solutions for government and commercial customers worldwide.
Based in Melbourne, the company has 46,000 full time employees and a market cap of $37.53 Billion. L3Harris Technologies currently returns an annual dividend yield of 2.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.